Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Lukic, Zana ^a   Goff, Stephen P ^b,c   Campbell, Edward M ^a   Arriagada, Gloria ^b,c,d  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

HIV 1; rhTRIM5 ; SIM; SUMO 1

Indexed keywords

EXPORTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTOMYCIN B; SUMO 1 PROTEIN; SUMO 2 PROTEIN; TRIPARTITE MOTIF PROTEIN 5;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RHESUS MONKEY; VIRUS CELL INTERACTION; VIRUS INHIBITION;

CELL LINE; DNA MUTATIONAL ANALYSIS; GENE KNOCKDOWN TECHNIQUES; HIV-1; HUMANS; NF-KAPPA B; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEINS; SUMO-1 PROTEIN;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MIRIDAE; MURINE LEUKEMIA VIRUS;

EID: 84873052425     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-10     Document Type: Article

References (33)

1. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005, 3:799-808. 10.1038/nrmicro1248, 16175175.
2. Nakayama EE, Miyoshi H, Nagai Y, Shioda T. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol 2005, 79:8870-8877. 10.1128/JVI.79.14.8870-8877.2005, 1168783, 15994780.
3. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 2004, 101:11827-11832. 10.1073/pnas.0403364101, 511059, 15280539.
4. Sebastian S, Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40. 10.1186/1742-4690-2-40, 1166576, 15967037.
5. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 2006, 103:5514-5519. 10.1073/pnas.0509996103, 1459386, 16540544.
6. Stremlau M, Perron M, Welikala S, Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol 2005, 79:3139-3145. 10.1128/JVI.79.5.3139-3145.2005, 548447, 15709033.
7. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 2004, 101:10774-10779. 10.1073/pnas.0402361101, 490010, 15249685.
8. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853. 10.1038/nature02343, 14985764.
9. Hay RT. SUMO: a history of modification. Mol Cell 2005, 18:1-12. 10.1016/j.molcel.2005.03.012, 15808504.
10. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007, 8:947-956. 10.1038/nrm2293, 18000527.
11. Minty A, Dumont X, Kaghad M, Caput D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem 2000, 275:36316-36323. 10.1074/jbc.M004293200, 10961991.
12. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem 2001, 276:21664-21669. 10.1074/jbc.M100006200, 11259410.
13. Hannich JT, Lewis A, Kroetz MB, Li SJ, Heide H, Emili A, Hochstrasser M. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J Biol Chem 2005, 280:4102-4110.
14. Song J, Zhang Z, Hu W, Chen Y. Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J Biol Chem 2005, 280:40122-40129. 10.1074/jbc.M507059200, 16204249.
15. Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I. Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem 2006, 281:16117-16127. 10.1074/jbc.M512757200, 16524884.
16. Arriagada G, Muntean LN, Goff SP. SUMO-interacting motifs of human TRIM5alpha are important for antiviral activity. PLoS Pathog 2011, 7:e1002019. 10.1371/journal.ppat.1002019, 3072370, 21490953.
17. McEwan WA, Schaller T, Ylinen LM, Hosie MJ, Towers GJ, Willett BJ. Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J Virol 2009, 83:8270-8275. 10.1128/JVI.00670-09, 2715776, 19494015.
18. Brandariz-Nunez A, Roa A, Valle-Casuso JC, Biris N, Ivanov D, Diaz-Griffero F. Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5alpha. Virology 2013, 435(2):463-471. Epub 2012 Oct 16, 10.1016/j.virol.2012.09.042, 23084420.
19. O'Connor C, Pertel T, Gray S, Robia SL, Bakowska JC, Luban J, Campbell EM. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. J Virol 2010, 84:5997-6006. 10.1128/JVI.02412-09, 2876647, 20357094.
20. Sebastian S, Grutter C, Strambio de Castillia C, Pertel T, Olivari S, Grutter MG, Luban J. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding. J Virol 2009, 83:3365-3373. 10.1128/JVI.00432-08, 2655600, 19153241.
21. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365. 10.1038/nature09976, 3081621, 21512573.
22. Tareen SU, Emerman M. Human Trim5alpha has additional activities that are uncoupled from retroviral capsid recognition. Virology 2011, 409:113-120. 10.1016/j.virol.2010.09.018, 3051842, 21035162.
23. Everett RD, Chelbi-Alix MK. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 2007, 89:819-830. 10.1016/j.biochi.2007.01.004, 17343971.
24. Lallemand-Breitenbach V, de The H. PML nuclear bodies. Cold Spring Harb Perspect Biol 2010, 2:a000661. 10.1101/cshperspect.a000661, 2857171, 20452955.
25. Diaz-Griffero F, Gallo DE, Hope TJ, Sodroski J. Trafficking of some old world primate TRIM5alpha proteins through the nucleus. Retrovirology 2011, 8:38. 10.1186/1742-4690-8-38, 3120760, 21575157.
26. Praefcke GJ, Hofmann K, Dohmen RJ. SUMO playing tag with ubiquitin. Trends Biochem Sci 2012, 37:23-31. 10.1016/j.tibs.2011.09.002, 22018829.
27. Biris N, Yang Y, Taylor AB, Tomashevski A, Guo M, Hart PJ, Diaz-Griffero F, Ivanov DN. Structure of the rhesus monkey TRIM5alpha PRYSPRY domain, the HIV capsid recognition module. Proc Natl Acad Sci U S A 2012, 109:13278-13283. 10.1073/pnas.1203536109, 3421187, 22847415.
28. Matunis MJ, Zhang XD, Ellis NA. SUMO: the glue that binds. Dev Cell 2006, 11:596-597. 10.1016/j.devcel.2006.10.011, 17084352.
29. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. The mechanisms of PML-nuclear body formation. Mol Cell 2006, 24:331-339. 10.1016/j.molcel.2006.09.013, 1978182, 17081985.
30. Kamitani T, Kito K, Nguyen HP, Wada H, Fukuda-Kamitani T, Yeh ET. Identification of three major sentrinization sites in PML. J Biol Chem 1998, 273:26675-26682. 10.1074/jbc.273.41.26675, 9756909.
31. Diaz-Griffero F, Li X, Javanbakht H, Song B, Welikala S, Stremlau M, Sodroski J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 2006, 349:300-315. 10.1016/j.virol.2005.12.040, 16472833.
32. Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573. 10.1038/nature02777, 15243629.
33. Sastri J, O'Connor C, Danielson CM, McRaven M, Perez P, Diaz-Griffero F, Campbell EM. Identification of residues within the L2 region of rhesus TRIM5alpha that are required for retroviral restriction and cytoplasmic body localization. Virology 2010, 405:259-266. 10.1016/j.virol.2010.06.015, 2914212, 20633914.